Professor and Chief of Vascular Surgery
University Medical Center Rotterdam
Professor
Erasmus University Medical Center Rotterdam
Rotterdam, The Netherlands
Presenter
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHSYMPOSIUM.ORG)
Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: What Are The Exceptions
9:41 AM - 9:46 AM
Presenter
SESSION 44: MORE NEW DEVELOPMENTS IN AAAS: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS
DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
2:42 PM - 2:47 PM